Cementos Bio Bio S.A. (SNSE:CEMENTOS)

Cementos Bio Bio Cash Flow Statement

Financials in millions CLP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	32,427	22,797	10,560	26,879	13,763
Depreciation & Amortization	-	26,869	26,581	23,439	14,401
Other Amortization	-	193.93	183.58	161.43	143.05
Asset Writedown & Restructuring Costs	-	584.07	2,550	991.27	3,504
Other Operating Activities	34,031	-9,009	-16,691	-25,634	1,754
Operating Cash Flow	66,459	41,435	23,183	25,836	33,565
Operating Cash Flow Growth	60.39%	78.73%	-10.27%	-23.03%	11.04%
Capital Expenditures	-12,123	-18,144	-13,808	-21,976	-9,339
Sale of Property, Plant & Equipment	1,504	917.43	361.43	27,337	658.63
Divestitures	-	-	80	-	79.81
Sale (Purchase) of Intangibles	-164.71	-182.8	-516.55	-78.51	-
Investing Cash Flow	-10,783	-17,410	-13,883	5,282	-8,600
Short-Term Debt Issued	8,306	6,976	18,809	4,853	20,000
Long-Term Debt Issued	-	-	-	-	10,000
Total Debt Issued	8,306	6,976	18,809	4,853	30,000
Long-Term Debt Repaid	-25,234	-21,465	-33,280	-13,259	-32,982
Net Debt Issued (Repaid)	-16,928	-14,489	-14,471	-8,405	-2,982
Common Dividends Paid	-27,082	-6,640	-24,974	-22,110	-2,786
Financing Cash Flow	-44,010	-21,129	-39,445	-30,515	-5,768
Foreign Exchange Rate Adjustments	640.88	49.01	-363.34	62.5	-16.59
Net Cash Flow	12,307	2,946	-30,509	665.62	19,180
Free Cash Flow	54,336	23,291	9,374	3,860	24,226
Free Cash Flow Growth	133.30%	148.45%	142.83%	-84.06%	36.25%
Free Cash Flow Margin	15.11%	6.67%	2.81%	1.33%	9.99%
Free Cash Flow Per Share	206.10	88.15	35.48	14.61	91.69
Cash Interest Paid	-	14,925	8,193	3,677	4,655
Cash Income Tax Paid	-	-8,038	1,146	4,874	2,683
Levered Free Cash Flow	14,894	15,534	8,739	-9,254	27,121
Unlevered Free Cash Flow	21,828	24,505	15,702	-7,028	29,645
Change in Net Working Capital	-9,644	6,035	3,872	19,252	-10,025

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.